Privacy Policy
  •  
  •  
Careers at XenoPort

Privacy Policy

About Your Privacy

XenoPort is committed to protecting the privacy of each user who visits our Web site. The following outlines our policy regarding your use of our Web site.

Personal Information

If you request company information through XenoPort.com, we will collect personally identifiable information such as your name, address, phone number and e-mail address. The personal data you provide is considered private and confidential. It will be collected by a third-party vendor that acts as a hosting service for our Web site, or that of the Rise and Shine Study web site. This information may also be retained by an outside vendor for storage purposes. We do not intend to otherwise share your identifiable personal information with others without your permission. We may refer you to Web sites that are directly linked to our site; if you access a linked site, please note that XenoPort is not responsible for the privacy or security policies of the linked Web sites.

Cookies

XenoPort uses "cookies", a standard technology that is used by many Web sites. A cookie is a small piece of data that is sent from a Web server to a Web browser and stored locally on the user's machine. The cookie is stored on the user's machine but is not an executable program. Cookies are managed by your browser. They enable us to track each time you revisit our site. If you do not want us to be able to track your visits to our site, you can disable cookies by turning them off in your browser.

Our cookies do not acquire any personally identifiable information. We use cookies to gather general traffic pattern and site usage information. We believe this allows us to continually improve our site for our users. XenoPort will not sell, trade, lease or reveal information that is obtained through cookies on your computer to any third party.

Future Updates

If XenoPort makes changes to this privacy policy, we will post new information on this page for your convenience.

"Medical advances and the efforts of the biopharmaceutical industry over the past several decades have provided society with an unprecedented number and variety of new medicines. Unfortunately, in some cases, these medicines have not reached their therapeutic potential and have left patients underserved. Utilizing our novel technology for improving drug bioavailability, XenoPort is in a unique position to create new medicines that extract the greatest therapeutic benefit from existing, sub-optimal drugs. It is this opportunity to improve the lives of patients that motivates XenoPort's employees to discover, develop and bring to market the medicines of the future."

—Ronald W. Barrett, Ph.D., CEO